ARCHIVES

In Congress: Time Running out On Effort To Double Market Exclusivity Term

This article is from The Cancer Letter archive.

Vol. 23 No. 43 | November 7, 1997

Download PDF Visit The Full Archive

Related Articles

ACS Adopts ‘Measures of Success’ To Mark Progress T0 Yr. 2000

April 17, 1992

FDA Discloses Avastin Regulatory History.

December 14, 2007

NCI Advisory Group, Other Cancer Meetings For Feb., March Listed

January 25, 1991

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

July 25, 2014

In Brief: Shingleton Probably Replacement For Marks On Panel; Connie Henke Heads Oncology Nurses

June 8, 1979

In Brief: AACR Grants Record Number Of Awards To Young Investigators; Kersey Leads ASBMT

April 24, 1998